Literature DB >> 10889927

Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma.

Q Chen1, L P Samaranayake, H Zhou, L Xiao.   

Abstract

A recently identified putative tumor-suppressor gene, PTEN, at 10q23 has been described as mutated or homozygously deleted in many different human tumors. To determine the role of the homozygous deletion of this PTEN gene in oral squamous cell carcinoma (OSCC), we screened two cell lines derived from the latter tissue and 28 tumor samples from patients with OSCC, using a differential display polymerase chain reaction (PCR) system and, direct DNA sequencing methods. All of the nine exons of the PTEN could be successfully amplified using DNA from tumor tissues and the cell lines using this system. DNA sequencing confirmed the accuracy of the PCR procedures. However, none of the samples, either from the cancer tissues or from the cell lines, showed homozygous deletion of PTEN. These data suggest that homozygous deletion of the PTEN gene is unlikely to be a feature of OSCCs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889927     DOI: 10.1016/s1368-8375(99)00068-8

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  11 in total

Review 1.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

2.  PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients.

Authors:  Nisreen Sherif Alyasiri; Syed Jafar Mehdi; M Shabbir Alam; Asgar Ali; Ashish K Mandal; Sunita Gupta; Ishwar Singh; M Moshahid Alam Rizvi
Journal:  J Cancer Res Clin Oncol       Date:  2011-10-28       Impact factor: 4.553

3.  Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.

Authors:  Punnya V Angadi; Rekha Krishnapillai
Journal:  Head Neck Pathol       Date:  2012-03-06

4.  ATM in oral carcinogenesis: association with clinicopathological features.

Authors:  Yuan He; Qianming Chen; Bingqi Li
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-21       Impact factor: 4.553

5.  MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia.

Authors:  Jia Yu; David G Ryan; Spiro Getsios; Michelle Oliveira-Fernandes; Anees Fatima; Robert M Lavker
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

6.  PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.

Authors:  Xu-Dong Yang; Su-Feng Zhao; Qian Zhang; Wei Li; Yu-Xin Wang; Xiao-Wei Hong; Qin-Gang Hu
Journal:  Tumour Biol       Date:  2015-08-02

Review 7.  Epigenetic disregulation in oral cancer.

Authors:  Massimo Mascolo; Maria Siano; Gennaro Ilardi; Daniela Russo; Francesco Merolla; Gaetano De Rosa; Stefania Staibano
Journal:  Int J Mol Sci       Date:  2012-02-21       Impact factor: 6.208

8.  Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus.

Authors:  J Snaddon; E K Parkinson; J A Craft; C Bartholomew; R Fulton
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

9.  Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.

Authors:  Longmei Cai; Yanfen Ye; Qiang Jiang; Yuxiang Chen; Xiaoming Lyu; Jinbang Li; Shuang Wang; Tengfei Liu; Hongbing Cai; Kaitai Yao; Ji-Liang Li; Xin Li
Journal:  Nat Commun       Date:  2015-07-02       Impact factor: 14.919

10.  Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.

Authors:  Xiao-Min Zhou; Rui Sun; Dong-Hua Luo; Jian Sun; Mei-Yin Zhang; Meng-He Wang; Yang Yang; Hui-Yun Wang; Shi-Juan Mai
Journal:  Oncotarget       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.